Back
Insulet Corp (PODD)
Health CarePODD · NASDAQ NMS - GLOBAL MARKET · USD
New to investing? How to read this page →$148.16
+0.88%Weekly undervalued picks
Price · 1 year
Loading live analysis…
Loading analysis…
Intrinsic Investor is for research and education only. Not financial advice.
Key metrics
EPS
$3.44
ROE
23.0%
Gross margin
71.0%
Debt/Equity
0.78x
Revenue growth
33.9%
Insulet Corp — company intelligence
Earnings surprises
Q2 2026$1.66 vs $1.48 est+12.2%
Q1 2026$1.42 vs $1.22 est+16.2%
Q4 2025$1.55 vs $1.48 est+4.5%
Q3 2025$1.24 vs $1.16 est+6.5%
Analyst consensus · 33 analysts
27 Buy6 Hold0 Sell
Updated Aug 16, 2026
Insider activity · 90 days
5 buys2 sellsnet +7,228 shares
Davis Lisa BlairSell 244 · Aug 1, 2026
MAZELSKY JONATHAN JAYBuy 1,355 · Jul 1, 2026
Huffines Robert LutherBuy 151 · Jun 30, 2026
Recent SEC filings
8-K — Material event reportAug 5, 2026
10-Q — Quarterly reportAug 5, 2026
4 — Insider transaction reportAug 4, 2026
Latest news
3 Mid-Cap Stocks with Competitive Advantages — Yahoo · 4d ago
Discover which S&P500 stocks are making waves on Tuesday. — ChartMill · 1w ago
5 Must-Read Analyst Questions From Insulet’s Q2 Earnings Call — Yahoo · 1w ago
Insulet Corporation’s (PODD) Wearable Pod Tech Finds New Frontier — Yahoo · 1w ago
Insulet (PODD) Q2 2026 Earnings Call Transcript — Yahoo · 1w ago
AI Valuation Narrative
Generates a short bull / bear / catalyst summary from the analytics we already computed. No target prices. Research tool, not investment advice.
Explore more
Peers & similar stocks
Quick links to related tickers for research.
Weekly undervalued picks
Get 3 new value ideas and the fair-value math behind them every week. One email, unsubscribe anytime.
Free. No spam. We only email once per week.
Data is provided "as-is" and may be delayed or incomplete. Intrinsic Investor is for education only and is not investment advice.